We are live on ! Find out more
SLXNW

Silexion Therapeutics Warrant
SLXNW

22 hedge funds and large institutions have $83.1K invested in Silexion Therapeutics Warrant in 2025 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 1

0% more funds holding

Funds holding: 22 → 22 (0)

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

3.24% less ownership

Funds ownership: 43.16% → 39.93% (-3.2%)

35% less capital invested

Capital invested by funds: $128K → $83.1K (-$44.4K)

Holders
22
Holders Change
–
Holders Change %
0%
% of All Funds
0.27%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
1
Reduced
1
Closed
1
Calls
$28K
Puts
–
Net Calls
+$28K
Net Calls Change
-$28K

Top Buyers

Rank Fund Capital Flow
1
HF
HRT Financial
New York
+$755
2
BOCH
Blue Owl Capital Holdings
New York
+$444
3
Goldman Sachs
Goldman Sachs
New York
+$163

Top Sellers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$7.75K
2
CS
Clear Street
New York
-$21
Name Holding Trade Value Shares
Change 		Change in
Stake
OMC
1
Oasis Management Company
Cayman Islands
$21.3K – – –
PAMP
2
Polar Asset Management Partners
Ontario, Canada
$19.3K – – –
LA
3
Linden Advisors
New York
$8.57K – – –
AC
4
Aristeia Capital
Connecticut
$6.29K – – –
CS
5
Clear Street
New York
$5.69K -$21 -600 -0.3%
SBLIC
6
Security Benefit Life Insurance Company
Kansas
$4.08K – – –
Goldman Sachs
7
Goldman Sachs
New York
$3.15K +$163 +4,598 +4%
KC
8
Kepos Capital
New York
$3K – – –
Jane Street
9
Jane Street
New York
$1.95K – – –
PMAM
10
Picton Mahoney Asset Management
Ontario, Canada
$1.49K – – –
CCM
11
Context Capital Management
California
$1.33K – – –
TCM
12
Tenor Capital Management
New York
$1.3K – – –
MTCM
13
Mint Tower Capital Management
Netherlands
$1K – – –
GCIA
14
Gabelli & Co Investment Advisers
New York
$992 – – –
DCM
15
Dupont Capital Management
Delaware
$884 – – –
Neuberger Berman Group
16
Neuberger Berman Group
New York
$820 – – –
GF
17
Gabelli Funds
New York
$793 – – –
Stifel Financial
18
Stifel Financial
Missouri
$416 – – –
BOCH
19
Blue Owl Capital Holdings
New York
$375 +$444 +12,500 New
SCM
20
Saba Capital Management
New York
$318 – – –
Bank of America
21
Bank of America
North Carolina
$3 – – –
Susquehanna International Group
22
Susquehanna International Group
Pennsylvania
– -$7.75K -220,053 Closed
HF
23
HRT Financial
New York
– +$755 +21,260 New

SLXNW Hedge Fund Activity: Q4 2025 in Review

22 of the 8,239 institutional investors tracked by Wall St. Rank reported a position in Silexion Therapeutics Warrant (SLXNW) for Q4 2025, worth a combined $83.1K — down 35% from $128K a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new SLXNW positions and 1 closed out — a net gain of 1 holder — while 1 added to existing stakes and 1 trimmed.

The largest buyer was HRT Financial, opening a new position worth an estimated $755. The largest seller was Susquehanna International Group, exiting entirely with an estimated $7.75K sold.

  • 22 institutional investors held Silexion Therapeutics Warrant (SLXNW) as of Q4 2025, unchanged from Q3 2025.
  • Funds reported $83.1K of Silexion Therapeutics Warrant stock for Q4 2025, down 35% quarter-over-quarter.
  • 2 funds opened new Silexion Therapeutics Warrant positions in Q4 2025 and 1 closed out, a net change of +1 holder.
  • The largest Silexion Therapeutics Warrant buyer in Q4 2025 was HRT Financial, an estimated $755 added.
  • The largest Silexion Therapeutics Warrant seller in Q4 2025 was Susquehanna International Group, an estimated $7.75K sold.

Based on aggregated 13F filings for Q4 2025.